Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Smeaton

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
The Journal of Infectious Diseases|August 10, 2005
Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milkRoger L Shapiro, Thumbi Ndung'u, Shahin Lockman, et al.
International Journal of Medical Informatics|March 24, 2004
Diagnostic accuracy of chest X-rays acquired using a digital camera for low-cost teleradiologyAgnieszka Szot, Francine L Jacobson, Samson Munn, et al.
HIV Clinical Trials|July 30, 2016
Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapyIsaac Singini, Thomas B Campbell, Laura M Smeaton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2014
Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227Mary A Vogler, Laura M Smeaton, Rodney L Wright, et al.
The Journal of Infectious Diseases|July 23, 2002
The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850)Arlene S Pereira, Laura M Smeaton, John G Gerber, et al.
The Journal of Infectious Diseases|May 15, 2020
Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune ActivationDonald D Anthony, Mark S Sulkowski, Laura M Smeaton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 23, 2006
Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group studyTodd Hulgan, Michael Hughes, Xin Sun, et al.
AIDS (London, England)|July 4, 2006
Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in BotswanaRoger L Shapiro, Ibou Thior, Peter B Gilbert, et al.
Annals of Internal Medicine|November 24, 2015
HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled TrialKaren T Tashima, Laura M Smeaton, Carl J Fichtenbaum, et al.
The New England Journal of Medicine|January 12, 2007
Response to antiretroviral therapy after a single, peripartum dose of nevirapineShahin Lockman, Roger L Shapiro, Laura M Smeaton, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The Journal of Infectious Diseases|August 10, 2005
Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milkRoger L Shapiro, Thumbi Ndung'u, Shahin Lockman, et al.
International Journal of Medical Informatics|March 24, 2004
Diagnostic accuracy of chest X-rays acquired using a digital camera for low-cost teleradiologyAgnieszka Szot, Francine L Jacobson, Samson Munn, et al.
HIV Clinical Trials|July 30, 2016
Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapyIsaac Singini, Thomas B Campbell, Laura M Smeaton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2014
Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227Mary A Vogler, Laura M Smeaton, Rodney L Wright, et al.
The Journal of Infectious Diseases|July 23, 2002
The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850)Arlene S Pereira, Laura M Smeaton, John G Gerber, et al.
The Journal of Infectious Diseases|May 15, 2020
Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune ActivationDonald D Anthony, Mark S Sulkowski, Laura M Smeaton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 23, 2006
Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group studyTodd Hulgan, Michael Hughes, Xin Sun, et al.
AIDS (London, England)|July 4, 2006
Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in BotswanaRoger L Shapiro, Ibou Thior, Peter B Gilbert, et al.
Annals of Internal Medicine|November 24, 2015
HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled TrialKaren T Tashima, Laura M Smeaton, Carl J Fichtenbaum, et al.
The New England Journal of Medicine|January 12, 2007
Response to antiretroviral therapy after a single, peripartum dose of nevirapineShahin Lockman, Roger L Shapiro, Laura M Smeaton, et al.
Pageof 3